A Multicenter, Randomized, Double-blind, Placebo- and Active-Controlled Study Comparing the Safety and Analgesic Efficacy of ABT-110 to Placebo in Subjects with Chronic Low Back Pain

Trial Profile

A Multicenter, Randomized, Double-blind, Placebo- and Active-Controlled Study Comparing the Safety and Analgesic Efficacy of ABT-110 to Placebo in Subjects with Chronic Low Back Pain

Discontinued
Phase of Trial: Phase II

Latest Information Update: 02 Mar 2013

At a glance

  • Drugs ABT 110 (Primary) ; Naproxen
  • Indications Back pain
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 02 Mar 2013 Planned number of patients changed from 390 to 330 as reported by EudraCT.
    • 12 Jan 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
    • 29 Dec 2012 Additional lead trial centre identified as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top